Stay updated with breaking news from Robert Den. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events - - First five patients received...
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events -
- 81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89% complete response rate.
(2022-07-05 | NDAQ:DRTS) Alpha Tau Hosting Key Opinion Leader Meeting on Alpha DaRT Clinical Trials
JERUSALEM, July 05, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau" or the “Company”), the developer of the innovative...